Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Argentine focus on cervical screening:

This article was originally published in Clinica

Executive Summary

Argentina's "high-complexity medical diagnostics institute" (IAMA) conducted ad hoc Papanicolaou (Pap) smear tests, human papilloma virus (HPV) screening and colposcopies over two days last week, in a bid to raise awareness of the importance of early detection of HPV and cervical cancer. The national incidence of HPV infections is currently 16.7%, says the health ministry, noting that the high rates (in the under-25-year age range) make cervical cancer the earliest form of cancer-related death among Argentine women. With early detection, however, the disease can be treated and managed, the Buenos Aires-based IAMA is stressing.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT047812

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel